Cargando…
Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway
Dihydromyricetin (DHM) is a flavonoid compound which possesses potent antitumor activity. In the present study, it was demonstrated that DHM significantly inhibited proliferation and induced apoptosis in mouse hepatocellular carcinoma Hepal-6 cells. Transforming growth factor β (TGF-β) is recognized...
Autores principales: | LIU, BIN, ZHOU, WEI, CHEN, XIAOFENG, XU, FENGMING, CHEN, YINQIN, LIU, JIE, ZHANG, QINGYU, BAO, SHITING, CHEN, NIANPING, LI, MINGYI, ZHU, RUNZHI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270327/ https://www.ncbi.nlm.nih.gov/pubmed/25376731 http://dx.doi.org/10.3892/mmr.2014.2891 |
Ejemplares similares
-
Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells
por: Wu, Shixing, et al.
Publicado: (2013) -
Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism
por: Zhang, Qingyu, et al.
Publicado: (2014) -
Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells
por: LIU, JIE, et al.
Publicado: (2014) -
Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells
por: LIU, BIN, et al.
Publicado: (2016) -
A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Lin, Bin, et al.
Publicado: (2014)